ClinicalTrials.gov
public full text
Public Domain
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
This project aims to provide high- quality evidence to inform decisions by health care organisations about using first-tier non-invasive prenatal screening (NIPS) to replace traditional screening tests for trisomy 21, and potentially to screen for other fetal chromosome anomalies. We will compare the current screening approach of second-tier NIPS with the use of first-tier NIPS in a large cohort of pregnant women.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ensuring Patients' Informed Access to Noninvasive Prenatal Testing#1196501
- T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients#883633
- Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)#1101267
- Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies#1095694
- The implementation of a national genomic newborn screening programme in the English NHS: Early lessons from the Generation Study#172140
Record · ID 1186073
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive